A phase 1 ascending dose study of a subcutaneously administered factor IXa inhibitor and its active control agent von VAVALLE, J. P., RUSCONI, C. P., ZELENKOFSKE, S., WARGIN, W. A., ALEXANDER, J. H., BECKER, R. C.

Volltext

PHASE 1 STUDY EVALUATING THE PHARMACOKINETICS, BIOAVAILABILITY, SAFETY, AND TOLERABILITY OF INTRANASALLY ADMINISTERED EPINEPHRINE POWDER von Francoeur, B., Wargin, W., Taubenheim, B., Lyman, S.

Volltext

The effect of the REG2 Anticoagulation System on thrombin generation kinetics: a pharmacodynamic and pharmacokinetic first-in-human study von Vavalle, J. P., Rusconi, C. P., Zelenkofske, S., Wargin, W. A., Ortel, T. L., Alexander, J. H., Povsic, T. J., Becker, R. C.

Volltext

Dose Selection for a Direct and Selective Factor IXa Inhibitor and its Complementary Reversal Agent: Translating Pharmacokinetic and Pharmacodynamic Properties of the REG1 System t... von Povsic, T. J., Cohen, M. G., Chan, M. Y., Zelenkofske, S. L., Wargin, W. A., Harrington, R. A., Alexander, J. H., Rusconi, C. P., Becker, R. C.

Volltext

Importance of the Organ-Independent Elimination of Cisatracurium von Kisor, David F., Schmith, Virginia D., Wargin, William A., Lien, Cynthia A., Ornstein, Eugene, Cook, D. Ryan

Volltext

Pharmacokinetics of RheothRx Injection in Healthy Male Volunteers von Jewell, R.C., Khor, S.P., Kisor, D.F., LaCroix, K.A.K., Wargin, W.A.

Volltext

Pegnivacogin results in near complete FIX inhibition in acute coronary syndrome patients: RADAR pharmacokinetic and pharmacodynamic substudy von Povsic, Thomas J., Wargin, William A., Alexander, John H., Krasnow, Joshua, Krolick, Merill, Cohen, Mauricio G., Mehran, Roxana, Buller, Christopher E., Bode, Christoph, Zelenkofske, Steven L., Rusconi, Christopher P., Becker, Richard C.

Volltext

The pharmacokinetics and pharmacodynamics of the stereoisomers of mivacurium in patients receiving nitrous oxide/opioid/barbiturate anesthesia von Lien, C A, Schmith, V D, Embree, P B, Belmont, M R, Wargin, W A, Savarese, J J

Volltext

Pharmacokinetics and safety of lamotrigine (Lamictal®) in patients with epilepsy von Ramsay, R.Eugene, Pellock, John M., Garnett, William R., Sanchez, Ramon M., Valakas, Antonia M., Wargin, William A., Lai, Alien A., Hubbell, James, Chern, W.H., Allsup, Thurman, Otto, Vicky

Volltext

Pharmacokinetic, bioavailability, and feasibility study of oral vinorelbine in patients with solid tumors von Rowinsky, E K, Noe, D A, Trump, D L, Winer, E P, Lucas, V S, Wargin, W A, Hohneker, J A, Lubejko, B, Sartorius, S E, Ettinger, D S

Volltext

Pharmacokinetics and Pharmacodynamics of Doxacurium in Young and Elderly Patients During Isoflurane Anesthesia von Dresner, David L., Basta, Salvatore J., Ali, Hassan H., Schwartz, Ann F., Embree, Patricia B., Wargin, William A., Lai, Allen A., Brady, Karen A., Savarese, John J.

Volltext

A phase 1/2 trial of HQK-1001, an oral fetal globin inducer, in sickle cell disease von Kutlar, Abdullah, Ataga, Kenneth, Reid, Marvin, Vichinsky, Elliott P., Neumayr, Lynne, Blair-Britt, Loray, Labotka, Richard, Glass, Jonathan, Keefer, Jeffrey R., Wargin, William A., Berenson, Ronald, Perrine, Susan P.

Volltext

THE PHARMACOKINETICS OF 1954U89, 1, 3-DIAMINO-7-(1-ETHYLPROPYL)-8-METHYL-7H-PYRROLO-(3, 2-f  )QUINAZOLINE, IN DOGS AND RATS AFTER INTRAVENOUS AND ORAL ADMINISTRATION von STUDENBERG, S. D., WOOLLEY, J. L., DEANGELIS, D. V., WARGIN, W. A.

Volltext

Contribution of Protein Binding to the Pharmacokinetics of the Ghrelin Receptor Agonist TZP-101 in Healthy Volunteers and Adults with Symptomatic Gastroparesis: Two Randomized, Dou... von Wargin, William, Thomas, Helmut, Clohs, Lilian, St-Louis, Carl, Ejskjaer, Niels, Gutierrez, Maria, Shaughnessy, Laura, Kosutic, Gordana

Volltext

Final clinical and pharmacokinetic (PK) results from a phase 1 study of the novel N-cadherin (N-cad) antagonist, Exherin (ADH-1), in patients with refractory solid tumors stratifie... von Stewart, D. J., Jonker, D. J., Goel, R., Goss, G., Maroun, J. A., Cripps, C. M., Wells, J., Wargin, W., Malik, R. K., Peters, W. P.

Volltext

Pharmacokinetics of Oral and Transdermal Triprolidine von Miles, Michael V., Balasubramanian, Ramadas, Pittman, A. Wayne, Grossman, Steven H., Pappa, Keith A., Smith, Mary Faye, Wargin, Willam A., Findlay, John W. A., Poust, Rolland I., Frosolono, Michael F.

Volltext

The effects of food and divided dosing on the bioavailability of oral vinorelbine von Rowinsky, E K, Lucas, V S, Hsieh, A L, Wargin, W A, Hohneker, J A, Lubejko, B, Sartorius, S E, Donehower, R C

Volltext

Crisnatol mesylate : phase I dose escalation by extending infusion duration von POPLIN, E. A, CHABOT, G. G, TUTTLE, R. L, WARGIN, W. A, BAKER, L. H

Volltext

Factors Associated With Nephrotoxicity and Clinical Outcome in Patients Receiving Amikacin von Williams, Paul J., Hull, J. Heyward, Sarubbi, Felix A., Rogers, John F., Wargin, William A.

Volltext

High-pressure liquid chromatographic assay for chloramphenicol, chloramphenicol-3-monosuccinate, and chloramphenicol-1-monosuccinate von Burke, J.T., Wargin, W.A., Blum, M.R.

Volltext